Record-setting metrics for Chinese Phase III Diabetes Study

Record-setting metrics for Chinese Phase III Diabetes Study

Access to large markets where clinical trials that can investigate real patient needs, and do so in a rapid fashion, is invaluable for clinical research organisations.  One such example of 乔治临 […]

了解更多

2016年10月20日

Hong Kong regulatory process for clinical trials has been revised

New legislation has taken into effect which simplifies the Hong Kong regulatory process for clinical trial application in that country

了解更多

2015年3月23日

Join Our Mailing List

required
required
required
required
I wish to subscribe to George Clinical communications.
required

在您的网络中添加 乔治临床( George Clinical )